Back to calendar
Relmada Therapeutics, Inc. (RLMD) Earnings
RLMD reports earnings on Thursday, November 5, 2026
earnings report
November 5, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.14
Actual EPS: $-0.11
Company overview
Market Cap$465.1M
SectorHealth Technology
IndustryPharmaceuticals: Major